약물 사용 장애 치료 : 세계 시장(-2030년)

The global substance use disorder (SUD) treatment market was valued at $11.6 billion in 2025, and it is expected to reach $14.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2030.

The North American substance use disorder (SUD) treatment market was valued at $4.2 billion in 2025, and it is projected to reach $5.4 billion by the end of 2030, at a CAGR of 4.8% from 2025 to 2030.

The APAC substance use disorder (SUD) treatment market was valued at $3 billion in 2025, and it is projected to reach $4 billion by the end of 2030, at a CAGR of 5.6% from 2025 to 2030.

Report Scope

This report presents an in-depth analysis of the global SUD treatment market by conditions, drugs, and geographic markets. BCC Research estimates market data for 2024 (the base year) and 2025 and forecasts values for 2026 through 2030. The report focuses on the major trends, challenges, and opportunities in the market and vendor landscape. It also covers the new products, acquisitions, and collaborations related to the market. The report also analyzes environmental, social, and corporate governance (ESG) developments.

The report concludes with an analysis of the competitive landscape for each condition. There is also a section of profiles of the leading companies.

Report Includes

• 25 data tables and 57 additional tables
• Overview and an analysis of the global market for substance use disorder treatment therapeutics
• Analyses of the global market trends, with historic revenue from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
• Estimates of the current market size and revenue prospects for the global market, accompanied by a market share analysis by condition (substance abuse), treatment type and region
• Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impact of macroeconomic variables
• Insights derived from Porter's Five Forces model, as well as global supply chain analyses
• Patent review, featuring key granted and published patents
• Analysis of the industry structure, including companies' market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the current status and ESG practices of leading companies
• Company profiles of major players within the industry, including Indivior PLC, Camurus AB, Alkermes, Dr. Reddy's Laboratories Ltd., and Braeburn Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics
• Emerging Trends
• Analysis by Segment
• Analysis by Region
• Conclusion

Chapter 2 Market Overview

• Substance Use Disorder Overview
• Analysis of Macroeconomic Factors
• Government Funding and Public Healthcare Budgets
• Income Inequality and Socioeconomic Status
• Labor Market Dynamics
• Global Supply Dynamics and the Macroeconomics of Illicit Markets
• Impact of U.S. Tariffs
• Porter's Five Forces Analysis
• Bargaining Power of Buyers: High
• Bargaining Power of Suppliers: Low to Moderate
• Threat of New Entrants: Moderate
• Threat of Substitutes: Moderate
• Industry Rivalry: High

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Widespread Global Prevalence of Substance Use Disorders
• Proliferation of Illicit Drugs
• Increasing Awareness of the Clinical Impact of Substance Use Disorders
• Increasing Government and Public Health Interventions
• Market Challenges
• Low Treatment Penetration Despite High Disease Burden
• Stigma and Social Barriers
• Market Trends
• Shift Toward Long-Acting and Sustained-Release Therapies
• Innovation in Drug Development
• Expansion of Telemedicine
• Digital-Pharmacologic Combination Therapies

Chapter 4 Regulatory Landscape

• Overview
• U.S.
• Key Federal Actors and Their Roles
• Europe
• European Medicines Agency (EMA)
• The European Union Drugs Agency (EUDA)
• Japan

Chapter 5 Emerging Technologies and Developments

• Emerging Technologies and Developments
• Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs)
• Psychedelics
• Clinical Trial Analysis
• By Condition Type
• By Funder Type
• Therapeutic Candidates in Late-Stage Clinical Trials

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Global Substance Use Disorder Treatment Market
• Nicotine Use Disorder
• Nicotine Replacement Therapy
• Varenicline
• Others
• Opioid Use Disorder
• Buprenorphine
• Methadone
• Naltrexone
• Alcohol Use Disorder
• Naltrexone
• Acamprosate
• Others
• Geographic Breakdown
• Global Substance Use Disorder Treatment Market, by Region
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America

Chapter 7 Competitive Intelligence

• Opioid Use Disorder
• Alcohol Use Disorder
• Nicotine Use Disorder

Chapter 8 Sustainability in Substance Use Disorder Treatment Market: An ESG Perspective

• Introduction to ESG
• Key ESG Issues Specific to the Substance Use Disorder Treatment Market
• Closing the Treatment Gap
• Community Engagement and Stigma Reduction
• Carbon Footprint Reduction
• Data Transparency and Outcomes Reporting
• Concluding Remarks

Chapter 9 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ACHIEVE LIFE SCIENCES INC.
• ADIAL PHARMACEUTICALS
• ALKERMES
• BRAEBURN INC.
• CAMURUS AB
• DA-PHARMA
• DR. REDDY'S LABORATORIES LTD.
• ETHYPHARM
• H. LUNDBECK A/S
• INDIVIOR PLC
• KENVUE
• LILLY USA LLC.
• NFL BIOSCIENCES
• OREXO AB (PUBL.)
• PAR HEALTH INC.
• Emerging Startups/Market Disruptors